원장 저서 및 논문
새숨길내과의원에 오신걸 환영합니다.
·
병원소개
·
원장 저서 및 논문
이승헌 원장 저서 및 논문
저서
결핵진료지침 3,4,5판 2014.2017,2020,2024.
대한결핵및호흡기학회. 질병관리청
대한결핵및호흡기학회. 질병관리청
북한 보건의료 연구와 협력
호흡기질환 북한의학 학술지를 통한 결핵연구 동향 분석. 2023. 고려대학교 출판문화원
호흡기질환 북한의학 학술지를 통한 결핵연구 동향 분석. 2023. 고려대학교 출판문화원
주요논문
1st author (제1저자)
1. A comparison of phenotype and WGS drug susceptibility testing in Mycobacterium tuberculosis isolates from the Republic of Korea.
JAC Antimicrob Resist. 2023 May 13:5
2. Intensive Care Unit Capacity and Its Associated Risk Factors During the COVID-19 Surge in the Republic of Korea:
Analysis Using Nationwide Health Claims Data. Risk Manag Health Policy 2020 Nov 12:13:2571-2581
3. Editorial. Active Case Finding in the Elderly Tuberculosis in South Korea. Tuberc Respir Dis (Seoul). 2019 Jul;82(3):261-263. 2019
4. Tuberculosis Infection and Latent Tuberculosis. Review. Tuberculosis and respiratory diseases
5. Longitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary Tuberculosis. PloS one 2016; 11: e0164039.
6. Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population.
BMC infectious diseases 2015; 15: 381.
7. Review. Diagnosis and treatment of latent tuberculosis infection. Tuberculosis and respiratory diseases 2015; 78: 56-63.
8. Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB.
Yonsei medical journal 2015; 56: 961-967.
9. Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis. American journal of respiratory
and critical care medicine 2013; 188: 858-864.
10. Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer. Yonsei medical journal 2013; 54: 1394-1399.
11. Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak.
Epidemiology and infection 2012; 140: 1028-1035.
12. Association between the interleukin-18 promoter polymorphism and pulmonary tuberculosis in a Korean population.
The international journal of tuberculosis and lung disease: the official journal of the International Union against
Tuberculosis and Lung Disease 2011; 15: 1246-1251
13. Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer.
Journal of Korean medical science 2011; 26: 67-70.
14. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respiratory medicine 2010; 104: 448-453.
15. Effect of matrix metalloproteinase-9-1562C/T gene polymorphism on manifestations of pulmonary tuberculosis.
Tuberculosis (Edinb) 2009; 89: 68-70.
16. Sequential bilateral lung resection in a patient with Mycobacterium abscessus lung disease refractory to medical treatment.
Yonsei medical journal 2010; 51: 141 144.
17. A case of granulomatous lung disease in a patient with Good's syndrome.
The 2016; 79: 201-206. Korean journal of internal medicine 2008; 23: 219-222.
1. A comparison of phenotype and WGS drug susceptibility testing in Mycobacterium tuberculosis isolates from the Republic of Korea.
JAC Antimicrob Resist. 2023 May 13:5
2. Intensive Care Unit Capacity and Its Associated Risk Factors During the COVID-19 Surge in the Republic of Korea:
Analysis Using Nationwide Health Claims Data. Risk Manag Health Policy 2020 Nov 12:13:2571-2581
3. Editorial. Active Case Finding in the Elderly Tuberculosis in South Korea. Tuberc Respir Dis (Seoul). 2019 Jul;82(3):261-263. 2019
4. Tuberculosis Infection and Latent Tuberculosis. Review. Tuberculosis and respiratory diseases
5. Longitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary Tuberculosis. PloS one 2016; 11: e0164039.
6. Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population.
BMC infectious diseases 2015; 15: 381.
7. Review. Diagnosis and treatment of latent tuberculosis infection. Tuberculosis and respiratory diseases 2015; 78: 56-63.
8. Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB.
Yonsei medical journal 2015; 56: 961-967.
9. Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis. American journal of respiratory
and critical care medicine 2013; 188: 858-864.
10. Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer. Yonsei medical journal 2013; 54: 1394-1399.
11. Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak.
Epidemiology and infection 2012; 140: 1028-1035.
12. Association between the interleukin-18 promoter polymorphism and pulmonary tuberculosis in a Korean population.
The international journal of tuberculosis and lung disease: the official journal of the International Union against
Tuberculosis and Lung Disease 2011; 15: 1246-1251
13. Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer.
Journal of Korean medical science 2011; 26: 67-70.
14. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respiratory medicine 2010; 104: 448-453.
15. Effect of matrix metalloproteinase-9-1562C/T gene polymorphism on manifestations of pulmonary tuberculosis.
Tuberculosis (Edinb) 2009; 89: 68-70.
16. Sequential bilateral lung resection in a patient with Mycobacterium abscessus lung disease refractory to medical treatment.
Yonsei medical journal 2010; 51: 141 144.
17. A case of granulomatous lung disease in a patient with Good's syndrome.
The 2016; 79: 201-206. Korean journal of internal medicine 2008; 23: 219-222.
주요논문
corresponding author (교신저자)
1. Discrepancies in tuberculosis burden estimates: North Korean defectors vs. official reports. Frontiers in Public Health 2025 May 30:13:1545628.
doi: 10.3389/fpubh 2025.1545628. eCollection 2025
2. Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco. PLoS One. 2022 Apr 19;17(4):e0267292
3. COVID-19 Disease Burden Related to Social Vulnerability and Comorbidities: Challenges to Tuberculosis Control.
Int J Environ Res Public Health. Mar 18 2022;19(6).
4. Policy Review and Modeling Analysis of Mitigation Measures for Coronavirus Disease Epidemic Control, Health System, and Disease Burden,
South Korea. Emerging Infectious Disease 2021 Nov 27:11
5. Cross-Contamination versus Outbreak: Pre-XDR Mycobacterial Strains Confirmed by Whole- Genome Sequencing. Antibiotics (Basel). 2021;10(3).
6. The Relationship Between Socio-Demographic Factors and Tuberculosis Mortality in the Republic of Korea During 2008-2017.
Front Public Health. 2021 Oct 20;9:691006
7. Comorbidities and Factors Determining Medical Expenses and Length of Stay for Admitted COVID-19 Patients in Korea.
Risk Manag Healthc Policy. 2021;14:2021-33
8. Experiences of Latent Tuberculosis Infection Treatment for the North Korean Refugees. Tuberc Respir Dis (Seoul). 2019 Oct;82(4):306-310.2019
9. Medication event monitoring system for infectious tuberculosis treatment in Morocco: A retrospective cohort study. The international journal of
environmental research and public health 2019 Jan 31;16(3). pii: E412
10. Comparing two Mycobacterium tuberculosis genomes from Chinese immigrants with native genomes using Mauve alignments.
Tuberculosis and respiratory diseases 2018 July; 81(3):216- 221
11. The cost-effectiveness of contact screening strategies for TB amongst school adolescents in South Korea. The international journal of
tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 2018 May 1;22(5):496-503
12. Lessons learned from continued TB outbreaks in a high school. PloS one 2017 Nov 16;12(11):e0188076.
13. Social and Clinical Characteristics of Immigrants with Tuberculosis in South Korea. Yonsei medical journal 2017; 58: 592-597.
14. Churg-Strauss syndrome that presented with mediastinal lymphadenopathy and calculous cholecystitis.
The Korean journal of internal medicine 2016; 31: 179-183.
15. The Prevalence Rate of Tuberculin Skin Test Positive by Contacts Group to Predict the Development of Active Tuberculosis After School Outbreaks.
Tuberculosis and respiratory diseases 2015; 78: 349-355.
16. Role of confirmatory interferon-gamma release assays in school outbreaks of tuberculosis in South Korea.
The international journal of tuberculosis and lung disease: the official journal of the International Union against
Tuberculosis and Lung Disease 2015; 19: 576-581.
17. Association between interleukin-27 polymorphisms and pulmonary tuberculosis. The international journal of tuberculosis and lung disease:
the official journal of the International Union against Tuberculosis and Lung Disease 2015; 19: 702-708.
18. Differences between Patients with TB-Destroyed Lung and Patients with COPD Admitted to the ICU.
Tuberculosis and respiratory diseases 2011; 70: 323-329.
1. Discrepancies in tuberculosis burden estimates: North Korean defectors vs. official reports. Frontiers in Public Health 2025 May 30:13:1545628.
doi: 10.3389/fpubh 2025.1545628. eCollection 2025
2. Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco. PLoS One. 2022 Apr 19;17(4):e0267292
3. COVID-19 Disease Burden Related to Social Vulnerability and Comorbidities: Challenges to Tuberculosis Control.
Int J Environ Res Public Health. Mar 18 2022;19(6).
4. Policy Review and Modeling Analysis of Mitigation Measures for Coronavirus Disease Epidemic Control, Health System, and Disease Burden,
South Korea. Emerging Infectious Disease 2021 Nov 27:11
5. Cross-Contamination versus Outbreak: Pre-XDR Mycobacterial Strains Confirmed by Whole- Genome Sequencing. Antibiotics (Basel). 2021;10(3).
6. The Relationship Between Socio-Demographic Factors and Tuberculosis Mortality in the Republic of Korea During 2008-2017.
Front Public Health. 2021 Oct 20;9:691006
7. Comorbidities and Factors Determining Medical Expenses and Length of Stay for Admitted COVID-19 Patients in Korea.
Risk Manag Healthc Policy. 2021;14:2021-33
8. Experiences of Latent Tuberculosis Infection Treatment for the North Korean Refugees. Tuberc Respir Dis (Seoul). 2019 Oct;82(4):306-310.2019
9. Medication event monitoring system for infectious tuberculosis treatment in Morocco: A retrospective cohort study. The international journal of
environmental research and public health 2019 Jan 31;16(3). pii: E412
10. Comparing two Mycobacterium tuberculosis genomes from Chinese immigrants with native genomes using Mauve alignments.
Tuberculosis and respiratory diseases 2018 July; 81(3):216- 221
11. The cost-effectiveness of contact screening strategies for TB amongst school adolescents in South Korea. The international journal of
tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 2018 May 1;22(5):496-503
12. Lessons learned from continued TB outbreaks in a high school. PloS one 2017 Nov 16;12(11):e0188076.
13. Social and Clinical Characteristics of Immigrants with Tuberculosis in South Korea. Yonsei medical journal 2017; 58: 592-597.
14. Churg-Strauss syndrome that presented with mediastinal lymphadenopathy and calculous cholecystitis.
The Korean journal of internal medicine 2016; 31: 179-183.
15. The Prevalence Rate of Tuberculin Skin Test Positive by Contacts Group to Predict the Development of Active Tuberculosis After School Outbreaks.
Tuberculosis and respiratory diseases 2015; 78: 349-355.
16. Role of confirmatory interferon-gamma release assays in school outbreaks of tuberculosis in South Korea.
The international journal of tuberculosis and lung disease: the official journal of the International Union against
Tuberculosis and Lung Disease 2015; 19: 576-581.
17. Association between interleukin-27 polymorphisms and pulmonary tuberculosis. The international journal of tuberculosis and lung disease:
the official journal of the International Union against Tuberculosis and Lung Disease 2015; 19: 702-708.
18. Differences between Patients with TB-Destroyed Lung and Patients with COPD Admitted to the ICU.
Tuberculosis and respiratory diseases 2011; 70: 323-329.